HeHealth launched Calmara AI, an app designed to help users assess their partner's STI status through image uploads. The app faced backlash for its privacy concerns and questionable accuracy, leading to an investigation by the Federal Trade Commission. Following the negative press, HeHealth decided to withdraw the app from the market.
The rise of AI-powered sexual health apps highlights the need for careful evaluation of their claims. Experts emphasize the importance of understanding the limitations of AI in medical contexts, particularly regarding sensitive health issues like STIs. The conversation around these technologies underscores the potential risks of prioritizing growth over user safety and privacy.
• Calmara AI app faced scrutiny for privacy and accuracy issues.
• Experts warn against oversimplified AI claims in sexual health applications.
The article discusses how machine learning is often misrepresented in health applications, leading to skepticism about their effectiveness.
The article highlights concerns about how HeHealth's training data may have contributed to biased results in their app.
The article stresses the importance of reviewing privacy policies for AI applications, especially in sensitive health contexts.
HeHealth's Calmara AI app faced significant backlash and regulatory scrutiny, leading to its withdrawal from the market.
The American Journal of Managed Care 7month
Isomorphic Labs, the AI drug discovery platform that was spun out of Google's DeepMind in 2021, has raised external capital for the first time. The $600
How to level up your teaching with AI. Discover how to use clones and GPTs in your classroom—personalized AI teaching is the future.
Trump's Third Term? AI already knows how this can be done. A study shows how OpenAI, Grok, DeepSeek & Google outline ways to dismantle U.S. democracy.
Sam Altman today revealed that OpenAI will release an open weight artificial intelligence model in the coming months. "We are excited to release a powerful new open-weight language model with reasoning in the coming months," Altman wrote on X.